作者
David D Bowtell, Steffen Böhm, Ahmed A Ahmed, Paul-Joseph Aspuria, Robert C Bast Jr, Valerie Beral, Jonathan S Berek, Michael J Birrer, Sarah Blagden, Michael A Bookman, James D Brenton, Katherine B Chiappinelli, Filipe Correia Martins, George Coukos, Ronny Drapkin, Richard Edmondson, Christina Fotopoulou, Hani Gabra, Jérôme Galon, Charlie Gourley, Valerie Heong, David G Huntsman, Marcin Iwanicki, Beth Y Karlan, Allyson Kaye, Ernst Lengyel, Douglas A Levine, Karen H Lu, Iain A McNeish, Usha Menon, Steven A Narod, Brad H Nelson, Kenneth P Nephew, Paul Pharoah, Daniel J Powell Jr, Pilar Ramos, Iris L Romero, Clare L Scott, Anil K Sood, Euan A Stronach, Frances R Balkwill
发表日期
2015/11
来源
Nature reviews Cancer
卷号
15
期号
11
页码范围
668-679
出版商
Nature Publishing Group UK
简介
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
学术搜索中的文章
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria… - Nature reviews Cancer, 2015